Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the activity on breathing parameters of 4
escalating doses of AVE0657 in comparison to placebo in patients with Cheynes-Stokes
Breathing Syndrome.